|
46
|
203
|
7dpqA |
Hiv-1 protease d30n mutant |
|
45
|
203
|
7dozA |
Hiv-1 protease d30n mutant in complex with nelfinavir |
|
17
|
99
|
7n6tA |
Crystal structure of inhibitor-free hiv-1 prs17 revertant mutant prs17 v48g |
|
19
|
99
|
7n6xA |
Crystal structure of hiv-1 protease multiple mutants prs17 bound to inhibitor amprenavir |
|
18
|
99
|
7n6vA |
Crystal structure of hiv-1 protease multiple mutants prs17 with revertant mutation v48g bound to inhibitor amprenavir |
|
19
|
99
|
7myyA |
Crystal structure of hiv-1 prs17 with grl-142 |
|
20
|
99
|
7mypA |
Crystal structure of hiv-1 prs17 with grl-44-10a |
|
18
|
99
|
6w6tA |
Wt hiv-1 protease in complex with phosphonated umass6 (pu6) |
|
20
|
116
|
6w6rA |
Wt htlv-1 protease in complex with umass6 (um6) |
|
19
|
116
|
6w6sA |
Wt htlv-1 protease in complex with phosphonated umass6 (pu6) |
|
20
|
116
|
6w6qA |
Wt htlv-1 protease in complex with darunavir (drv) |
|
18
|
99
|
6uwcA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-08613 |
|
20
|
99
|
6uwbA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-08513 |
|
18
|
99
|
6vodA |
Hiv-1 wild type protease with grl-052-16a, a tricyclic cyclohexane fused tetrahydrofuranofuran (chf-thf) derivative as the p2 ligand |
|
19
|
99
|
6voeA |
Hiv-1 wild type protease with grl-019-17a, a tricyclic cyclohexane fused tetrahydrofuranofuran (chf-thf) derivative as the p2 ligand and a aminobenzothiazole(abt)-based p2'-ligand |
|
19
|
99
|
6vceA |
Hiv-1 wild type protease with grl-026-18a, a crown-like tetrahydropyranotetrahydrofuran with a bridged methylene group as a p2 ligand |
|
18
|
99
|
6pjeA |
Hiv-1 protease nl4-3 wt in complex with lr2-43 |
|
17
|
99
|
6pjbA |
Hiv-1 protease nl4-3 wt in complex with lopinavir |
|
17
|
99
|
6pjgA |
Hiv-1 protease nl4-3 wt in complex with lr3-97 |
|
16
|
99
|
6pjiA |
Hiv-1 protease nl4-3 wt in complex with lr3-43 |
|
17
|
99
|
6pjoA |
Hiv-1 protease nl4-3 wt in complex with lr2-42 |
|
15
|
99
|
6pjlA |
Hiv-1 protease nl4-3 wt in complex with lr3-95 |
|
17
|
99
|
6pjfA |
Hiv-1 protease nl4-3 wt in complex with lr2-44 |
|
17
|
99
|
6pjnA |
Hiv-1 protease nl4-3 wt in complex with lr2-41 |
|
18
|
99
|
6pjcA |
Hiv-1 protease nl4-3 wt in complex with lr4-41 |
|
17
|
99
|
6pu8A |
Room temperature x-ray structure of hiv-1 protease triple mutant (v32i,i47v,v82i) with tetrahedral intermediate of keto-darunavir |
|
18
|
99
|
6pjdA |
Hiv-1 protease nl4-3 wt in complex with lr2-32 |
|
16
|
99
|
6ptpA |
Joint x-ray/neutron structure of hiv-1 protease triple mutant (v32i,i47v,v82i) with tetrahedral intermediate mimic kvs-1 |
|
18
|
99
|
6pjkA |
Hiv-1 protease nl4-3 wt in complex with lr3-29 |
|
18
|
99
|
6pjmA |
Hiv-1 protease nl4-3 wt in complex with lr2-35 |
|
17
|
99
|
6pjhA |
Hiv-1 protease nl4-3 wt in complex with lr3-28 |
|
20
|
99
|
6oydA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-004 |
|
20
|
99
|
6oyrA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-002 |
|
8
|
99
|
1bveA |
Hiv-1 protease-dmp323 complex in solution, nmr, 28 structures |
|
18
|
99
|
6c8xA |
Wild-type hiv-1 protease in complex with a phenylboronic acid (p2') analog of darunavir |
|
17
|
99
|
6dj2A |
Hiv-1 protease with single mutation l76v in complex with lopinavir |
|
18
|
99
|
6dv4A |
Hiv-1 wild type protease with grl-04315a, a tetrahydronaphthalene carboxamide with (r)-boc-amine and (s)-hydroxyl functionalities as the p2 ligand |
|
19
|
99
|
6dj1A |
Wild-type hiv-1 protease in complex with lopinavir |
|
17
|
99
|
6dv0A |
Hiv-1 wild type protease with grl-02815a, a thiochroman heterocycle with (s)-boc-amine functionality as the p2 ligand |
|
17
|
99
|
6dilA |
Hiv-1 protease with single mutation l76v in complex with tipranavir |
|
19
|
99
|
6e7jA |
Hiv-1 wild type protease with grl-042-17a, 3-phenylhexahydro-2h-cyclopenta[d]oxazol-2-one with a bicyclic oxazolidinone scaffold as the p2 ligand |
|
19
|
99
|
6c8yA |
D30n hiv-1 protease in complex with a phenylboronic acid (p2') analog of darunavir |
|
18
|
99
|
6difA |
Wild-type hiv-1 protease in complex with tipranavir |
|
19
|
99
|
6e9aA |
Hiv-1 wild type protease with grl-034-17a, (3as, 5r, 6ar)-2-oxohexahyd cyclopenta[d]-5-oxazolyl urethane with a bicyclic oxazolidinone scaff as the p2 ligand |
|
16
|
99
|
6dj7A |
Hiv-1 protease with mutation l76v in complex with grl-5010 (gem-difluoro-bis-tetrahydrofuran as p2 ligand) |
|
17
|
99
|
6dj5A |
Hiv-1 protease with mutation l76v in complex with grl-0519 (tris-tetrahydrofuran as p2 ligand) |
|
18
|
99
|
6dh6A |
Crystal structure of hiv-1 protease nl4-3 i50v mutant in complex with darunavir |
|
18
|
99
|
6dh2A |
Crystal structure of hiv-1 protease nl4-3 i84v mutant in complex with umass6 |
|
18
|
99
|
6dgyA |
Crystal structure of hiv-1 protease nl4-3 wt in complex with umass1 |
|
17
|
99
|
6dh8A |
Crystal structure of hiv-1 protease nl4-3 i50v mutant in complex with umass6 |
